Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
09/2012
09/06/2012US20120225055 Antigen binding proteins
09/06/2012US20120225045 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
09/06/2012US20120225041 Methods and compositions for treating tissue using silk proteins
09/06/2012US20120225014 Antibodies to cd40
09/05/2012EP2495568A1 Method for determining sensitivity to an anticancer agent
09/05/2012EP2495561A1 Anticancer agent sensitivity-determining marker
09/05/2012EP2495323A1 Modified double-stranded polynucleotide
09/05/2012EP2495243A1 Novel 5-fluorouracil derivative
09/05/2012EP2495238A1 Novel 3-hydroxy-5-arylisoxazole derivative
09/05/2012EP2494990A1 Agent for regeneration and/or protection of nerves
09/05/2012EP2494977A1 Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood
09/05/2012EP2493514A1 Sterilization of biodegradable hydrogels
09/05/2012EP2493295A1 Methods to mitigate injury from radiation exposure
09/05/2012EP2493293A1 Methods for maintaining eye health and ameliorating opthalmic maladies in canines
09/05/2012CN1980656B New pharmaceutical use of lipase inhibitor
09/05/2012CN1639569B Methods and compositions for inducing an immune response
09/05/2012CN1636572B Compositions and methods for treatment of mitochondrial diseases
09/05/2012CN1635909B Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
09/05/2012CN1514729B Sustained-release analgesic compounds
09/05/2012CN1165483B Compositions of ciplatin in comination with 2,2'-dithio-bis (ethanesulfonate) (dinesna)
09/05/2012CN102656172A 8-oxodihydropurine derivative
09/05/2012CN102656149A Benzamide compound
09/05/2012CN102655866A Therapeutic or prophylactic agent for diabetes
09/05/2012CN102655863A Heparanase activity inhibitor
09/05/2012CN102653522A Omega-carboxy-substituted diphenylthiourea compounds, and preparation method and application thereof
09/05/2012CN102652785A Liuwei Dihuang decoction total extract composition and preparation method and application thereof to preparation of drugs for treating heart, brain and testis complications caused by stress response
09/05/2012CN102652729A Magnetic nanomaterials and methods for chemoembolisation
09/05/2012CN102133392B Water splashing compound preparation for boosting exuviation of shrimps and crabs, hardening shells, preventing diseases and resisting stresses
09/05/2012CN102091107B Method for extracting total triterpene of centella asiatica by enzymic process
09/05/2012CN102068549B Detection method for Chinese medicinal preparation heat clearing and blood cooling pills
09/05/2012CN101918363B Phenyl acetamide derivative
09/05/2012CN101880222B Square acid derivate and preparation method thereof
09/05/2012CN101878201B Fused indane compound
09/05/2012CN101642570B Application of carbon monoxide-releasing molecules and heparin in preparing medicament for treating sepsis
09/05/2012CN101638423B Phloridzin derivative as well as preparation method and application thereof
09/05/2012CN101590120B Application of traditional Chinese medicine composition in preparing medicament for proliferating endothelial progenitor cells of peripheral blood of human body
09/05/2012CN101583377B Treatment of fibrosis
09/05/2012CN101160291B Novel hsp90 inhibitor
09/04/2012US8258293 Tetrahydroquinoline derivatives
09/04/2012US8258288 RNA interference mediated inhibition of respiratory syncytial virus (RSV) expression using short interfering nucleic acid (siNA)
09/04/2012US8258174 Method of inhibiting apoptosis
09/04/2012US8258133 2-amino-bicyclo[3.1.0]hexane-2, 6-dicarboxylic ester derivative
09/04/2012US8258132 Pharmaceutical composition of a tachykinin receptor antagonist
09/04/2012US8258106 Immunostimulatory nucleic acid molecules
09/04/2012US8257741 Solid pharmaceutical dispersions with enhanced bioavailability
09/04/2012CA2501819C Imidazole derivative and their use as peripherally-selective inhibitors of dopa nine-beta-hydroxylase
09/04/2012CA2432971C Polypeptides
08/2012
08/30/2012WO2012115247A1 Stratum corneum peeling accelerator
08/30/2012WO2012115209A1 Soluble epoxide hydrolase inhibitor
08/30/2012WO2012115182A1 Therapeutic agent for corneal sensory nerve damage containing semaphorin inhibitor as active ingredient
08/30/2012WO2012115097A1 Glycine transport inhibitor
08/30/2012WO2012115066A1 Glycine transport inhibitor
08/30/2012WO2012115064A1 Ppar activator
08/30/2012WO2012091081A8 Interferon production-inducing agent containing lactic acid bacteria
08/30/2012US20120220648 Method of Treating Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency Using Adeno-Associated Virus (AAV)-AADC Vector
08/30/2012US20120220631 USE OF 5H-THIOENO(3,4-c)PYRROLE-4,6-DIONE DERIVATIVES AS TUMOR NECROSIS FACTOR INHIBITOR
08/30/2012US20120220599 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
08/30/2012US20120220559 Controlled Release and Taste Masking Oral Pharmaceutical Composition
08/30/2012US20120219970 Methods for modulating macrophage proliferation in ocular disease using polyamine analogs
08/30/2012US20120219566 Compositions and methods of treating t cell mediated disorder
08/30/2012US20120219554 Extracellular yaluronidase from streptomyces koganeiensis
08/30/2012US20120219529 Silver ion compositions of pectins
08/30/2012CA2827372A1 Glycine transporter-inhibiting substances
08/29/2012EP2492262A1 Fused heterocyclic compound and thrombopoietin receptor activator
08/29/2012EP2490687A1 Compositions for treatment of cystic fibrosis and other chronic diseases
08/29/2012EP2490533A1 Novel compositions for preventing and/or treating lysosomal storage disorders
08/29/2012CN1735435B Agent improving proton-driven transporter-mediated absorption in digestive tract and process for producing the same
08/29/2012CN1678633B Anti-IGF-I receptor antibody
08/29/2012CN102648978A Stable protein pharmaceutical preparation and preparation method thereof
08/29/2012CN102178911B Chinese medicine preparation used for dispelling wind and eliminating dampness, dredging collaterals and stopping pains for people with deficiency of yang and phlegm dampness constitution, and preparation method and application of preparation
08/29/2012CN101961447B Novel preparation method, preparation and application of Chinese medicinal composition
08/29/2012CN101955477B 2-cyclopropyl-4-substituted thiophenyl quinoline compounds as well as intermediate, preparation method and application thereof
08/29/2012CN101909619B Composition comprising sesamin component and quercetin glycoside
08/29/2012CN101633646B Salts of valsartan
08/29/2012CN101574475B Polygonatum particle and preparation method thereof
08/29/2012CN101574391B Prevention and treatment of diseases induced by microcirculation disturbance with compatible combination of total salvianolic acid and panax notoginoside
08/29/2012CN101443344B Trehalose compound and pharmaceutical comprising the compound
08/29/2012CN101163684B Quinazoline derivative having tyrosine kinase inhibitory activity
08/28/2012US8252929 8-carboxamido-2,6-methano-3-benzazocines
08/28/2012US8252923 Peptidomimetic protease inhibitors
08/28/2012US8252909 Synthetic C-glycolipid and its use for treating cancer, infectious diseases, and autoimmune diseases
08/28/2012US8252818 Nicotinamide derivatives useful as P38 inhibitors
08/28/2012US8252815 Nociceptin analogs
08/28/2012US8252537 5' portion of an intestinal lactase-phlorizine hydrolase (LPH) gene; point mutations; solid phase synthesis; immunoassay; vectors; primers; host cells; antibodies; kits; gene therapy
08/28/2012US8252524 Method of screening pharmaceutical compositions that promote nuclear transfer of Cdc42 protein
08/28/2012US8252322 Delivery system with increased bioavailability
08/28/2012CA2550441C Benzimidazole derivatives and medical uses thereof
08/28/2012CA2479414C Inhibition of the .beta.3 subunit of l-type ca2+ channels
08/28/2012CA2476939C Pharmaceutical combinations of cox-2 inhibitors and opiates
08/28/2012CA2455710C Calcium salts with cytotoxic activity
08/28/2012CA2454073C Mutations in ion channels
08/28/2012CA2437812C Compositions and methods for modulation of vascular structure and/or function
08/28/2012CA2395632C A bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins
08/23/2012WO2012111795A1 Ameliorating agent for lifestyle-related diseases containing water extract of colored onion
08/23/2012WO2012111790A1 Potentiator of antitumor activity of chemotherapeutic agent
08/23/2012WO2012111643A1 Adiponectin production promoter, and medicinal composition, food, drink and feed containing adiponectin production promoter
08/23/2012WO2012111187A1 Skin collagen production promoter
08/23/2012WO2012110768A1 Therapeutic uses of diarylalkanes such as mitotane
08/23/2012WO2012110456A1 Absorbent dressings with painkilling activity
08/23/2012US20120214870 Methods for diagnosis and treatment of chronic fatigue syndrome
1 ... 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 ... 1564